Innovative Medicines
COMCMT1R-EP1R-C2R-EPCNCADO
Updated 155mo ago
This procedure concerns the formal approval of the 2011 budget expenditure for the Innovative Medicines Initiative (IMI). The European Parliament reviews how the funds were managed to ensure the budget was used efficiently and according to the law.
This affects the management of the IMI partnership and its stakeholders, ensuring accountability for public funds spent on pharmaceutical research and development.